This protective effect extends to human cellular models, where USP8 knockdown promotes lysosomal degradation of α‐Synuclein, and to midbrain dopaminergic neurons, where it safeguards against α‐Synuclein‐induced dysfunction [135], illuminating its critical role in PD pathology. Here, USP8 is linked to Parkinson disease.